Plain-English translation of NCT07024992 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a smartphone app called ESCAPE can help Black adults with HIV quit smoking. The app is designed specifically for your community and focuses on managing stress, anxiety, and nicotine withdrawal symptoms. You'll also receive nicotine replacement therapy (like patches or gum) to support your quit attempt.
Black adults with HIV face unique challenges when trying to quit smoking, including higher stress and anxiety. This study wants to see if a culturally tailored app — one designed specifically for your experiences — can be more effective at helping people quit than standard smoking cessation programs.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of three groups: the ESCAPE app plus nicotine replacement therapy, a standard National Cancer Institute smoking cessation app plus nicotine replacement therapy, or nicotine replacement therapy alone. Over 54 weeks, you'll complete a baseline appointment, answer brief survey questions on your phone multiple times per week, attend monthly check-in visits, and have follow-up visits at 28 weeks and 54 weeks. Some participants will also be asked to do a brief interview at week 6. The whole process takes about one year.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
United States